Live from the NIH registry
Studies recruiting near Fort Wayne right now
Top 25 of 115 recruiting studies, sorted by proximity — each links to its official registry page
Open-Label Study to Evaluate the Safety, Tolerability, PK, and Efficacy of INX-315 in Patients With Advanced Cancer
Breast Cancer, Breast Cancer Metastatic
Phase 1, Phase 2
Interventional 150 participants sought
Fort Wayne Medical Oncology and Hematology — Fort Wayne, Indiana (3.0 mi)
· Sponsor: Incyclix Bio
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
Advanced Pancreatic Carcinoma, Metastatic Pancreatic Carcinoma
Phase 2
Interventional 40 participants sought
Ohio State University-Telemedicine — Fort Wayne, Indiana (3.0 mi)
· Sponsor: Sameek Roychowdhury
A Phase 3 Efficacy and Safety Study of HBS-301 in Participants With Idiopathic Hypersomnia (IH)
Idiopathic Hypersomnia
Phase 3
Interventional 248 participants sought
Fort Wayne Neurological Center — Fort Wayne, Indiana (3.0 mi)
· Sponsor: Harmony Biosciences Management, Inc.
Integrated Cancer Repository for Cancer Research
Multiple conditions
N/A
Observational 999,999 participants sought
Parkview Research Center — Fort Wayne, Indiana (3.0 mi)
· Sponsor: University of Nebraska
Study of Trastuzumab Deruxtecan Versus Standard of Care Chemotherapy for HER2-Expressing (IHC 3+/2+) Endometrial Cancer
Endometrial Cancer
Phase 3
Interventional 710 participants sought
Parkview Research Center — Fort Wayne, Indiana (3.0 mi)
· Sponsor: Daiichi Sankyo
C-Brace Prospective Registry
Pareses, Lower Extremity
N/A
Observational 250 participants sought
Prevail Prosthetics & Orthotics — Fort Wayne, Indiana (3.0 mi)
· Sponsor: Otto Bock Healthcare Products GmbH
A Study of Dostarlimab vs Placebo After Chemoradiation in Adult Participants With Locally Advanced Unresected Head and Neck Squamous Cell Carcinoma
Neoplasms, Head and Neck
Phase 3
Interventional 864 participants sought
GSK Investigational Site — Fort Wayne, Indiana (3.0 mi)
· Sponsor: GlaxoSmithKline
BGB-43395 Plus Letrozole Versus CDK4/6i Plus Letrozole for Patients With Advanced or Metastatic HR+/HER2- Breast Cancer Who Have Not Received Prior Treatment for Advanced or Metastatic Disease
HR+/HER2- Breast Cancer
Phase 3
Interventional 1,056 participants sought
Fort Wayne Medical Oncology and Hematology — Fort Wayne, Indiana (3.0 mi)
· Sponsor: BeOne Medicines
A Study to Investigate the Efficacy of an Experimental Dentifrice Containing Stannous Fluoride in Improving Gingival Health
Dental Plaque, Gingivitis
N/A
Interventional 110 participants sought
Salus Research Inc — Fort Wayne, Indiana (3.0 mi)
· Sponsor: HALEON
REdo tranScatheter Aortic Valve Replacement for Transcatheter aOrtic Valve failuRE
Aortic Stenosis
N/A
Observational 225 participants sought
Parkview Health — Fort Wayne, Indiana (3.0 mi)
· Sponsor: Medtronic Cardiovascular
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
End Stage Kidney Disease
Phase 2, Phase 3
Interventional 3,110 participants sought
NANI Research — Fort Wayne, Indiana (3.0 mi)
· Sponsor: CSL Behring
A Study of HS-20110 in Participants With Advanced Solid Tumors
Solid Tumors
Phase 1
Interventional 475 participants sought
Fort Wayne Medical Oncology and Hematology — Fort Wayne, Indiana (3.0 mi)
· Sponsor: Hansoh BioMedical R&D Company
Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer
Metastatic Colorectal Cancer (CRC)
Phase 3
Interventional 600 participants sought
Clinical Study Site — Fort Wayne, Indiana (3.0 mi)
· Sponsor: Summit Therapeutics
Testing Docetaxel-Cetuximab or the Addition of an Immunotherapy Drug, Atezolizumab, to the Usual Chemotherapy and Radiation Therapy in High-Risk Head and Neck Cancer
Oropharyngeal p16INK4a-Negative Squamous Cell Carcinoma, Stage III Hypopharyngeal Squamous Cell Carcinoma AJCC v7
Phase 2, Phase 3
Interventional 613 participants sought
Radiation Oncology Associates PC — Fort Wayne, Indiana (3.0 mi)
· Sponsor: National Cancer Institute (NCI)
The Happy Families Project: Testing the Effectiveness of a Conflict Resolution Program for Families
Mental Health, Conflict
N/A
Interventional 1,800 participants sought
Fort Wayne Center for Children and Families — Fort Wayne, Indiana (3.0 mi)
· Sponsor: University of Notre Dame
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
Breast Neoplasms, Triple Negative Breast Neoplasms
Phase 3
Interventional 2,400 participants sought
Fort Wayne Medical Oncology and Hematology ( Site 0084) — Fort Wayne, Indiana (3.0 mi)
· Sponsor: Merck Sharp & Dohme LLC
AZD5335 vs. Mirvetuximab Soravtansine in FRα-high and AZD5335 vs. Chemotherapy in FRα-low Platinum-resistant Ovarian Cancer
Epithelial Ovarian Cancer
Phase 3
Interventional 1,100 participants sought
Research Site — Fort Wayne, Indiana (3.0 mi)
· Sponsor: AstraZeneca
A Safety and Dose-finding Study of PRL-02 Depot in Men With Advanced Prostate Cancer
Prostate Cancer, Metastatic Castration Resistant Prostate Cancer
Phase 1
Interventional 174 participants sought
Fort Wayne Medical Oncology and Hematology, Inc. — Fort Wayne, Indiana (3.0 mi)
· Sponsor: Astellas Pharma Global Development, Inc.
Cognitive Impairment in Colorectal Cancer Patients Receiving Cytotoxic Chemotherapy
Neoplasm, Colorectal, Cognitive Impairment
N/A
Observational 60 participants sought
Parkview Cancer Institute — Fort Wayne, Indiana (3.0 mi)
· Sponsor: Joseph McCollom
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube High Grade Serous Adenocarcinoma
Phase 3
Interventional 880 participants sought
Parkview Regional Medical Center — Fort Wayne, Indiana (3.0 mi)
· Sponsor: NRG Oncology
A Study of Dato-DXd in Inoperable or Metastatic Hormone Receptor-positive, HER2 IHC 0 Breast Cancer
Breast Cancer
Phase 3
Interventional 100 participants sought
Research Site — Fort Wayne, Indiana (3.0 mi)
· Sponsor: AstraZeneca
A Study to Learn About the Study Medicine Called PF-07328948 in Adults With Heart Failure (BRANCH-HF)
Heart Failure
Phase 2
Interventional 620 participants sought
NexGen Research — Fort Wayne, Indiana (3.0 mi)
· Sponsor: Pfizer
Safety and Efficacy of Flaus Electric Flosser on Plaque and Gingivitis Compared to a Manual Toothbrush
Gingivitis, Gingival Bleeding
N/A
Interventional 80 participants sought
Salus Research, Inc. — Fort Wayne, Indiana (3.0 mi)
· Sponsor: Flaus, Inc
A Study to Evaluate the Safety, Tolerability, and Efficacy of Pumitamig Alone or in Combination With Other Agents in Participants With Advanced Renal Cell Carcinoma (RCC) (ROSETTA RCC-208)
Advanced Renal Cell Carcinoma (RCC)
Phase 1, Phase 2
Interventional 474 participants sought
Local Institution - 0170 — Fort Wayne, Indiana (3.0 mi)
· Sponsor: Bristol-Myers Squibb
ONC-392 Versus Docetaxel in Metastatic NSCLC That Progressed on PD-1/PD-L1 Inhibitors
Non Small Cell Lung Cancer
Phase 3
Interventional 630 participants sought
Fort Wayne Medical Oncology - 1133 — Fort Wayne, Indiana (3.0 mi)
· Sponsor: OncoC4, Inc.